**Core Concept**
Bisphosphonates are a class of medications used to treat osteoporosis and other bone-related disorders by inhibiting osteoclast-mediated bone resorption. This action helps to maintain or increase bone density, thereby reducing the risk of fractures.

**Why the Correct Answer is Right**
Bisphosphonates bind to hydroxyapatite in bone tissue, which then inhibits the enzyme farnesyl pyrophosphate synthase. This inhibition disrupts the mevalonate pathway, ultimately leading to the apoptosis of osteoclasts, the cells responsible for bone resorption. This results in a decrease in bone turnover and an increase in bone density.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the action of bisphosphonates, which primarily target osteoclasts and bone resorption, not bone formation or muscle relaxation.
**Option B:** This option is incorrect because bisphosphonates do not directly affect vitamin D metabolism or calcium absorption, although both are important factors in bone health.
**Option C:** This option is not accurate because bisphosphonates do not have a significant effect on bone formation, which is primarily mediated by osteoblasts.

**Clinical Pearl / High-Yield Fact**
Bisphosphonates have a long half-life in bone tissue, which allows for infrequent dosing and can lead to prolonged inhibition of osteoclast activity. This property makes them useful for the treatment of conditions like osteoporosis.

**Correct Answer:** C.